Browse Related Topics For:

Pharmaceutical Industry The United States Food and Drug Administration

378
Prescription Drugs
225
Biosimilars
194
Generic Drugs
185
Patents
175
Pharmaceutical Patents
167
Medical Devices
121
BPCIA
121
Patent Litigation
119
Patent Infringement
109
ANDA
108
Off-Label Promotion
102
Biologics
91
Healthcare
82
Hatch-Waxman
80
FDCA
75
First Amendment
69
Amgen
66
Sandoz
61
Labeling
60
Popular
59
Manufacturers
59
Off-Label Use
57
Sandoz v Amgen
56
Draft Guidance
46
Amarin
46
Preemption
46
SCOTUS
45
FDA Approval
43
HHS
41
Clinical Trials
41
Life Sciences
37
Free Speech
36
Affordable Care Act
36
Medicare
34
Misbranding
33
21st Century Cures Initiative
33
Medicaid
32
FTC
32
Marketing
30
Advertising
30
Failure To Warn
29
Patent Dance
29
Preliminary Injunctions
28
Drug Compounding
28
Health Care Providers
28
Pharmacies
27
Patent-in-Suit
26
Warning Labels
25
CMS
25
Commercial Speech
24
Appeals
24
Biotechnology
23
Commercial Marketing
23
False Claims Act (FCA)
22
Intellectual Property Protection
21
Product Labels
21
Trump Administration
20
DOJ
20
Enforcement Actions
20
Medical Research
20
NIH
19
Drug Pricing
19
Physicians
18
aBLA
18
Apotex
18
Comment Period
18
Drug Safety
18
Orphan Drugs
17
AbbVie
17
Mylan Pharmaceuticals
16
Biologics Price Competition and Innovation Act of 2009
16
Caronia
16
Citizen Petitions
16
EU
16
Teva Pharmaceuticals
15
Class Action
15
New Guidance
15
Notice Requirements
15
Patent Applications
15
Safe Harbors
14
Antitrust Litigation
14
Corporate Counsel
14
Final Rules
14
Hospira
14
Hospitals
14
PHRMA
14
Social Media
14
USPTO
14
Warning Letters
13
DSCSA
13
FFDCA
13
Final Guidance
13
Healthcare Reform
13
Public Health Service Act
13
Reverse Payment Settlement Agreements
13
Settlement
13
Summary Judgment
12
Declaratory Judgments
12
HIPAA
12
Johnson & Johnson
12
Legislative Agendas
12
OIG
12
Pfizer
12
Proposed Regulation
11
Bayer
11
DQSA
11
Fraud
11
GlaxoSmithKline
11
Innovation
11
Multidistrict Litigation
11
Product Exclusivity
11
Public Meetings
11
Research and Development
11
SEC
11
Supply Chain
10
Discovery
10
Enforcement
10
FTC v Actavis
10
Health Insurance
10
Interchangeability
10
Obviousness
10
PLIVA v Mensing
10
Professional Conferences
10
Proposed Legislation
10
Public Health
10
Regulatory Standards
10
Reporting Requirements
9
Antitrust Violations
9
Birth Defects
9
Civil Monetary Penalty
9
Cybersecurity
9
Design Defects
9
Drug Approvals
9
European Medicines Agency (EMA)
9
Negligence
9
Opioid
9
Pending Legislation
9
Personal Jurisdiction
9
Prior Art
9
Public Comment
9
Section 340B
9
Social Networks
9
Trademarks
8
21st Century Cures Act
8
3D Printing
8
Actavis Inc.
8
Criminal Prosecution
8
Drug Distribution
8
False Advertising
8
Inter Partes Review (IPR) Proceeding
8
Janssen Pharmaceuticals
8
Medicare Part D
8
Misleading Statements
8
Orange Book
8
Product Defects
8
Qui Tam
8
Regulatory Oversight
8
REMS
8
Whistleblowers
7
Adverse Events
7
Cancer
7
CDC
7
Certiorari
7
Congressional Investigations & Hearings
7
Disclosure Requirements
7
Health Information Technologies
7
HRSA
7
Investigational New Drug Application (IND)
7
Merck
7
Motion to Dismiss
7
Novartis
7
Patent Invalidity
7
Pay-For-Delay
7
PHSA
7
Product Hopping
7
Product Recalls
7
Public Hearing
7
Sherman Act
7
Side Effects
7
Standing
7
Watson Pharmaceuticals
6
Abbott Laboratories
6
Administrative Procedure Act
6
Anti-Kickback Statute
6
Barack Obama
6
Black Box Warnings
6
CHIP
6
Competition
6
Compliance
6
Eli Lilly
6
Expert Testimony
6
Federal Funding
6
Federal Rules of Civil Procedure
6
FOIA
6
GAO
6
Inadequate Warning
6
Informed Consent
6
OMB
6
Otsuka Pharmaceutical
6
PDUFA
6
Pleading Standards
6
Scientific Research
6
Securities Fraud
6
Strict Liability
6
Unfair or Deceptive Trade Practices
6
User Fees
6
Websites
6
World Health Organization
5
Allergan Inc
5
America Invents Act
5
Anti-Competitive
5
Brand
5
Canada
5
Causation
5
DEA
5
Diagnostic Tests
5
Exclusivity
5
Federal Rule 12(b)(6)
5
Fifth Amendment
5
Food and Drug Administration Amendments Act (FDAAA)
5
HCEI
5
Illegal Drugs
5
Infringement
5
Injunctive Relief
5
Insider Trading
5
Investigational New Drug procedures (IND)
5
Jurisdiction
5
Learned Intermediary
5
Medicare Part B
5
Medtronic
5
Mergers
5
Misrepresentation
5
Monopolization
5
On-Sale Bar
5
OPDP
5
Patent Term Extensions
5
Personalized Medicine
5
Regulatory Agenda
5
Securities Litigation
5
Unfair Competition
5
USDA
4
Advisory Committee
4
Amgen v Sandoz
4
Antitrust Provisions
4
Big Data
4
Boehringer
4
Celebrity Endorsements
4
CGMP
4
Claim Construction
4
Class Certification
4
Classen Immunotherapies
4
Databases
4
Dietary Supplements
4
DNA
4
Durable Medical Equipment
4
Elan Pharmaceuticals
4
Endo Pharmaceuticals
4
EPA
4
Evidence
4
FCPA
4
FD&C Act
4
FDA Warning Letters
4
FDASIA
4
Genetic Testing
4
Healthcare Fraud
4
Home Health Care
4
IRS
4
Kickbacks
4
Laboratory Developed Tests
4
Lanham Act
4
Legislative Committees
4
Licenses
4
Long Term Care Facilities
4
MedPAC
4
Mensing
4
Mental Health
4
Misleading Impressions
4
New Legislation
4
No-AG Agreement
4
Outsourcing
4
OxyContin
4
Patent Trial and Appeal Board
4
Patient Safety
4
Patients
4
Permanent Injunctions
4
Pregnancy
4
Risk Assessment
4
Risk Management
4
Samsung
4
Secretary of HHS
4
Settlement Agreements
4
Shareholders
4
Substance Abuse
4
Technology
4
Trade Secrets
4
Transparency
4
UAW
4
Verification Requirements
4
Wholesale
3
510(k) RTA
3
Acquisitions
3
Allergan v Sandoz
3
Article III
3
Biogen Idec
3
Biopharmaceutical
3
Bristol-Myers Squibb
3
Burden of Proof
3
Celltrion
3
Center for Drug Evaluation and Research (CDER)
3
CEOs
3
Chevron Deference
3
China
3
Clinical Laboratories
3
Confidential Information
3
Conflicts of Interest
3
Contraceptives
3
Controlled Substances Act
3
Covered Entities
3
Data Protection
3
Daubert Standards
3
Declaratory Relief
3
Disgorgement
3
Dismissals
3
Due Process
3
EHR
3
Employee Benefits
3
Exclusive Dealing Agreements
3
False Statements
3
Federal Budget
3
Federal Register
3
Financial Conduct Authority (FCA)
3
Financial Markets
3
Food Recalls
3
Foreign Manufacturers
3
Genentech
3
Generic
3
Genzyme
3
Google
3
Guidance Update
3
Hackers
3
Healthcare Facilities
3
Imports
3
Innovator Liability
3
Inspections
3
Intellectual Property Litigation
3
Internet
3
Interstate Commerce
3
Inventors
3
IRB
3
Kim Kardashian
3
License Agreements
3
Medical Malpractice
3
Medicare Advantage
3
Method Claims
3
Mutual Pharmaceuticals v Bartlett
3
Notice Provisions
3
OCR
3
openFDA
3
Pain Management
3
Patent-Eligible Subject Matter
3
Patient Privacy Rights
3
Petition for Writ of Certiorari
3
Premarket Approval Applications
3
Prescription Drug Coverage
3
Private Right of Action
3
PSLRA
3
Public Disclosure
3
Public Health Insurance Marketplace
3
Purple Book
3
Putative Class Actions
3
Quality Control Plan
3
Rule-of-Reason Analysis
3
Rulemaking Process
3
Sealed Records
3
Securities
3
Securities Violations
3
SNDAs
3
Software
3
Stark Law
3
Strategic Enforcement Plan
3
Subject Matter Jurisdiction
3
Sunshine Act
3
Takeda Pharmaceuticals
3
Tax Credits
3
Telemedicine
3
Twitter
3
Twombly/Iqbal Pleading Standard
3
Venture Capital
3
Veterinary Products
3
Wrongful Death
3
Wyeth
2
ACOs
2
All Writs Act
2
American Medical Association
2
Amgen v Apotex
2
Amicus Briefs
2
AMP v Myriad
2
Animal Drugs
2
Animal Testing
2
Antibiotics
2
Antitrust Injuries
2
AstraZeneca
2
Attorney Generals
2
Attorney-Client Privilege
2
Audits
2
Bifurcation
2
Biometric Information
2
CAFC
2
Capital Raising
2
Cephalon
2
Chemicals
2
Clear and Convincing Evidence
2
Coherus
2
Combination Products
2
Consumer Fraud
2
Controlled Substances
2
Conversion
2
Corporate Integrity Agreement
2
Cosmetics
2
Counterclaims
2
Counterfeit Drugs
2
Crowdfunding
2
Cyber Threats
2
Daiichi Sankyo
2
DaimlerChrysler v Bauman
2
Data Breach
2
De Novo Standard of Review
2
Digital Health
2
Direct to Consumer Sales
2
Disclaimers
2
Diversity Jurisdiction
2
DMEPOS
2
Dodd-Frank
2
Drug & Alcohol Abuse
2
Duty to Deal
2
Duty to Warn
2
Ethics
2
Executive Orders
2
Exemptions
2
Extrapolation
2
Failure To Disclose
2
Federal Health Care Programs (FHCP)
2
Federal Question Jurisdiction
2
Federal v State Law Application
2
Financial Sector
2
First Impression
2
First-to-File
2
Fraudulent Joinder
2
FSMA
2
GDUFA
2
General Jurisdiction
2
Gilead Sciences
2
Government Investigations
2
GPOs
2
Health Insurance Exchanges
2
Health Safety
2
HITECH
2
HIV
2
Human Rights
2
Indictments
2
Induced Infringement
2
Injunctions
2
Inpatient Prospective Payment System (IPPS)
2
Insurance Industry
2
Internal Controls
2
International Arbitration
2
Internet Marketing
2
Investigational Device Exemptions
2
Investment
2
Investors
2
IP License
2
Licensing Rules
2
Manufacturing Defects
2
Marijuana
2
Marketing Authorization Application
2
Medicaid Expansion
2
Medical Reimbursement
2
Medicare Prescription Drug Improvement and Modernization Act (MMA)
2
Mental Health Parity Rule
2
Mobile Apps
2
Mootness
2
NAFTA
2
National Cancer Moonshot
2
Native American Issues
2
Negligent Misrepresentation
2
Nike
2
Non-Public Information
2
Obama Administration
2
Omissions
2
Omnibus Guidance
2
Omnicare
2
Omnicare v Laborers District Council
2
Online Advertisements
2
Outsourcing Facilities
2
Over-the-Counter Sales
2
Par Pharmaceutical
2
Pay-Per-Click
2
PCORI
2
Pediatrics
2
Personally Identifiable Information
2
Pharmacist
2
POM Wonderful
2
Post-Grant Review
2
Presidential Elections
2
Price Gouging
2
Public Safety
2
Publicly-Traded Companies
2
Qualified Small Employer Health Reimbursement Plan (QSEHRAs)
2
RanBaxy
2
Registration Requirement
2
Regulatory Reform
2
Reimbursements
2
Relators
2
Repeal
2
Reverse Payments
2
RICO
2
Right to Try
2
Ripeness
2
Risk Mitigation
2
Safety Precautions
2
Samsung Bioepis
2
Sanctions
2
Sanofi
2
Schering-Plough
2
Scientific Evidence
2
Search Engines
2
Section 503
2
Securities Exchange Act
2
Skilled Nursing Facility
2
Small Business
2
Solicitor General
2
Spectrum
2
Standard of Review
2
Startups
2
Statute of Limitations
2
Stem cells
2
Stock Drop Litigation
2
Stocks
2
Subsidies
2
Tax Deductions
2
Telehealth
2
Testimony
2
The Common Rule
2
Transfer of Venue
2
TRO
2
Two-Midnight Rule
2
UK
2
Universal Health Services Inc v United States ex rel Escobar
2
User-Generated Content
2
Warner Chilcott
2
Warranties
2
Webinars
2
Written Descriptions
2
Yates Memorandum
2
Young Lawyers
1
23andMe
1
35 U.S.C. § 271(e)(1)
1
Acceleration
1
Accounting Controls
1
Actos
1
Actual Injuries
1
Addiction Equity Act
1
Additive Manufacturing
1
Administrative Appointments
1
Administrative Authority
1
Administrative Proceedings
1
Admissible Evidence
1
Advance Notice
1
Advisory Opinions
1
Aerospace
1
AHRQ
1
AIDS
1
AIG
1
ALJ
1
All Natural
1
Alzheimer's
1
Amazon
1
Ambulatory Surgery Centers
1
Amended Complaints
1
Amended Regulation
1
Amended Rules
1
American Health Care Act (AHCA)
1
Amgen Inc. v Connecticut Retirement Plans
1
Animal Food
1
Animal Health
1
Anti-Monopoly
1
Anti-Retaliation Provisions
1
Anti-Steering Rules
1
Antimicrobials
1
Antitrust Conspiracies
1
App Developers
1
Applicable Manufacturers
1
Applications
1
Appointments Clause
1
Appropriate Equitable Relief
1
Arbitration
1
Article II
1
Artificial Intelligence
1
Asbestos
1
Asbestos Litigation
1
Asia
1
Assignments
1
Attestation Deadlines
1
Aurobindo Pharmaceuticals
1
Australia
1
Automobile Recall
1
Automotive Industry
1
Bank of New York (BNY) Mellon
1
Banking Sector
1
Barclays
1
Bayh-Dole Act
1
Benefit Plan Reimbursements
1
Best Buy
1
Best Management Practices
1
Best Practices
1
Billing
1
Bilski
1
biologic
1
Bipolar Disorder
1
Birth Control Pill
1
Boston Scientific
1
BPCI
1
Brand Name Prescription Drugs
1
Breach of Duty
1
Breach of Implied Contract
1
Breach of Warranty
1
Breakthrough Therapy Designation
1
Budget Cuts
1
Build America Investment Initiative
1
Business Associates
1
Business Development
1
C&DIs
1
CA Supreme Court
1
Campaign Finance Reform
1
Canadian Intellectual Property Office
1
Cartwright Act
1
Carve Out Provisions
1
Caterpillar
1
CCIIO
1
CERCLA
1
Certification Requirements
1
CFPB
1
Chief Compliance Officers
1
Childrens' Motrin
1
Chilling Effect
1
Chip and PIN
1
Cipro
1
Citizen Suits
1
Claim Preclusion
1
Clean Air Act
1
Clean Water Act
1
clear
1
Clearance
1
CLIA
1
Climate Action Plan
1
Clinical Laboratory Testing
1
CLS Bank v Alice Corp
1
CMMI
1
Co-payments
1
COBRA
1
Coca Cola
1
Collateral Estoppel
1
Commerce Clause
1
Commitment Letter
1
Common Law Claims
1
Community Health Systems
1
Compensation & Benefits
1
Compensatory Awards
1
Compensatory Damages
1
Competitive Bidding
1
Complete Genomics
1
Comptroller of the Treasury v Wynne
1
Confidential Documents
1
Conflicting Proposals
1
Congressional Budget Office
1
Congressional Committees
1
Congressional Review Act
1
Consent Decrees
1
Conspiracies
1
Constitutional Challenges
1
Consumer Product Safety Commission (CPSC)
1
Consumer Protection Act
1
Consumers Legal Remedies Act
1
Contamination
1
Contests & Promotions
1
Continuing Medical Education
1
Contraceptive Coverage Mandate
1
Contract Drafting
1
Contributory Infringement
1
Copyright
1
Corporate Misconduct
1
Corporate Officers
1
Corporate Taxes
1
Corrective Actions
1
Corruption
1
Cost-Sharing
1
Costco
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Covered Recipients
1
CPUC
1
CREATE Act
1
Criminal Convictions
1
Cross Motions
1
Cross-Border Transactions
1
Cruel & Unusual Punishment
1
Cuozzo Speed Technologies v Lee
1
Customs and Border Protection
1
CVM
1
Cyber Attacks
1
DaimlerAG
1
Data Breach Plans
1
Data Controller
1
Data Integrity
1
Data Mining
1
Data Security
1
Daubert Ruling
1
De Minimis Claims
1
Debit and Credit Card Transactions
1
Debt Ceiling
1
Deceptive Intent
1
Defect
1
Defense Strategies
1
Delaware General Corporation Law
1
Delays
1
Department of Transportation (DOT)
1
Department of Veterans Affairs
1
Depositions
1
Derivation Proceeding
1
Device Classification
1
DHS
1
Diagnostic Imaging Services
1
Diagnostic Method
1
Direct Infringement
1
Direct Purchasers
1
Dirks v SEC
1
Disability Discrimination
1
Disclosure
1
Discounts
1
Discussion Draft
1
Disruptive Technology
1
Distributors
1
Divided Infringement
1
Document Retention Policies
1
DOL
1
Domain Names
1
Double Jeopardy
1
Drug Testing
1
Drug Treatment
1
DSHEA
1
DSM
1
Due Diligence
1
E-Filing
1
EAR
1
Earn-Outs
1
EEOC
1
Eighth Amendment
1
Electronic Communications
1
Electronic Filing
1
Electronic Health Record Incentives
1
Electronic Records
1
Electronically Stored Information
1
Eleventh Amendment
1
Email
1
Embargo
1
Emerging Markets
1
Employer Group Health Plans
1
Employer Mandates
1
En Banc Review
1
Environmental Policies
1
ERISA
1
Ernst & Young
1
EU-US Privacy Shield
1
European Food Safety Authority (EFSA)
1
Events
1
Evidence Suppression
1
Evidentiary Standards
1
Ex Post Facto Clause
1
Excessive Pricing
1
Excise Tax
1
Expedited FDA Approval
1
Expert Witness
1
Export Controls
1
Exports
1
Failure To State A Claim
1
Fair Notice
1
False Evidence
1
False Press Release
1
Falsified Documents
1
Fast Track Process
1
FBI
1
FCC
1
FDA Commissioner
1
FDAMA
1
Federal Aviation Administration (FAA)
1
Federal Contractors
1
Federal Pilot Programs
1
Federal Rule 12(b)(1)
1
FedEx
1
Fee-for-Service
1
Fee-Shifting
1
FERC
1
Fiduciary Duty
1
Fiduciary Rule
1
Financial Choice Act
1
Financial Institutions
1
Flame Retardant
1
Flexible Spending Accounts
1
FMCSA
1
Food Allergies
1
Food Labeling
1
Food Poisoning
1
Foreign Corporations
1
Foreign Earned Income
1
Foreign Investment
1
Foreign Tax
1
Foreseeability
1
Form 10-K
1
Form 8-K
1
Forum Shopping
1
Fraud-on-the-Market
1
FRCP 26
1
FSMB
1
FTC Act
1
Funding
1
General Electric
1
General Services Administration (GSA)
1
General Wellness Devices
1
Genetic Markers
1
Genetic Materials
1
Goldman Sachs
1
Good Cause
1
Good Clinical Practices
1
Goodyear
1
Government Studies
1
Grable Factors
1
Grocery Stores
1
gTLD
1
Guilty Pleas
1
Halliburton v Erica P. John Fund
1
Hazardous Substances
1
Hazardous Waste
1
HCPCS
1
Health & Safety Standard
1
Health Canada
1
Health Care Violations
1
Health IT
1
Health Savings Accounts
1
Healthcare Costs
1
Hedge Funds
1
HELP
1
Hewlett-Packard
1
Hoffman LaRoche
1
Home Depot
1
Homeopathic Remedies
1
Honeybees
1
Hospice
1
Hospital Mergers
1
HRA
1
Human Genes
1
Human Genome Project
1
ICD-10
1
Illegal Tipping
1
Implied Certification
1
Implied Preemption
1
In-Person Exam
1
Incentives
1
Incident Response Plans
1
Income Taxes
1
Indirect Infringement
1
Individual Mandate
1
Inducement
1
Infectious Diseases
1
Information Reports
1
Information Sharing
1
Initial Public Offerings
1
Inpatient Rehab Facilities
1
Integra
1
Inter Partes Reexamination
1
intercha
1
InterDigital Communications v ITC
1
Interest Rate Adjustments
1
Interest Rates
1
InterMune
1
International Harmonization
1
Internet of Things
1
Internet Retailers
1
INTERPOL
1
Interpretive Rule
1
Inventions
1
Investment Adviser
1
Investment Advisers Act of 1940
1
Investment Trust Companies
1
Iran Sanctions
1
IRF Claim Processing
1
Issue Preclusion
1
JAMA
1
Janssen v Celltrion
1
Janus Capital Group
1
Joinder
1
Joint Venture
1
Journalists
1
Judicial Review
1
Jury Awards
1
Jury Trial
1
Justiciable Controversy
1
King v Burwell
1
KPMG
1
LabMD
1
Law Enforcement
1
Leave to Amend
1
Legal History
1
Legal Perspectives
1
License Applications
1
Lipitor
1
Litigation Hold
1
Litigation Privilege
1
Lobbyists
1
Local Ordinance
1
Loss Causation
1
MA Supreme Court
1
Managed Care Contracts
1
Manufacturing Facilities
1
Marijuana Cultivation
1
Marijuana Related Businesses
1
Market Manipulation
1
Market Research
1
MasterCard
1
Material Misrepresentation
1
Material Misstatements
1
Materiality
1
MCOs
1
Medicaid Act
1
Medical Foods
1
Medical Liability
1
Medical Supplies
1
Medicare Access and CHIP Reauthorization (MACRA)
1
Medicare Modernization Act
1
Memorandum of Understanding
1
Mental Health Initiatives
1
Merrill Lynch v Manning
1
Methane
1
Midnight Rules Relief
1
Minor Children
1
Mobile Health Apps
1
Motion for Reconsideration
1
Motion To Centralize
1
Motion to Remand
1
Motion To Stay
1
Motions in Limine
1
Motor Carriers
1
Murder
1
NAD
1
Nanomedicine
1
Nanotechnology
1
Natural Products
1
Negligence Per Se
1
Negligent Design
1
New Regulations
1
New Trial
1
Nexus
1
NJ Supreme Court
1
Noerr-Pennington Doctrine
1
Non-Disclosure Agreement
1
Non-Practicing Entities
1
Notice and Comment
1
Notice of Appeal
1
Notifications
1
NPRM
1
Numerosity
1
Nursing Homes
1
OECD
1
OEHHA
1
OFAC
1
Off-Campus Departments
1
Office of Scientific Investigations (OSI)
1
OFVM
1
Oil & Gas
1
ONC
1
Online Platforms
1
Online Reviews
1
Open Enrollment
1
OPPS
1
Opt-Outs
1
OTC
1
Out-of-State Companies
1
Out-of-State Judgments
1
Overpayment
1
Parallel Claims
1
Partnerships
1
PATENT Act
1
Patent Cooperation Treaty
1
Patent Exhaustion
1
Patent Expiration
1
Patent Filings
1
Patent Portfolios
1
Patent Reform
1
Patent-Misuse
1
Patient Assistance Programs